(Q33707148)

28 July 2017

1 reference

title

Methods for measuring and monitoring medication regimen adherence in clinical trials and clinical practice (English)

1 reference

28 July 2017

Farmer KC

1

1 reference

28 July 2017

language of work or name

1 reference

1 June 1999

1 reference

28 July 2017

published in

Clinical Therapeutics

1 reference

28 July 2017

volume

21

1 reference

28 July 2017

issue

6

1 reference

28 July 2017

page(s)

1074-90; discussion 1073

1 reference

Systematic review of randomised trials of interventions to assist patients to follow prescriptions for medications

28 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980026-5

7 January 2021

Pill count, self-report, and pharmacy claims data to measure medication adherence in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980026-5

7 January 2021

Non-compliance--or how many aunts has Matilda?

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980026-5

7 January 2021

The relationship of treatment adherence to the risk of death after myocardial infarction in women

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980026-5

7 January 2021

Discontinuation of antihyperlipidemic drugs--do rates reported in clinical trials reflect rates in primary care settings?

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980026-5

7 January 2021

The run-in period in clinical trials. The effect of misclassification on efficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980026-5

7 January 2021

Problems of spectrum and bias in evaluating the efficacy of diagnostic tests

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980026-5

7 January 2021

Can simple clinical measurements detect patient noncompliance?

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980026-5

7 January 2021

Critical comparison of novel and existing methods of compliance assessment during a clinical trial of an oral iron chelator

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980026-5

7 January 2021

Accuracy of indirect measures of medication compliance in hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980026-5

7 January 2021

Reporting compliance in clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980026-5

7 January 2021

Time to stop counting the tablets?

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980026-5

7 January 2021

Nondichotomous patterns of medication usage: the yes-no fallacy

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980026-5

7 January 2021

A comparison of patient dosage deviation reports with pill counts

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980026-5

7 January 2021

Screening for noncompliance among patients with hypertension: is self-report the best available measure?

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980026-5

7 January 2021

Out-patient compliance with antidepressant medication

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980026-5

7 January 2021

Studies of doctor-patient interaction

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980026-5

7 January 2021

Variations in patients' compliance with doctors' advice: an empirical analysis of patterns o communication

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980026-5

7 January 2021

Patient compliance--whose responsibility?

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980026-5

7 January 2021

Antecedents of adherence to medical recommendations: results from the Medical Outcomes Study

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980026-5

7 January 2021

The validity of an interview to assess a patient's drug taking

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980026-5

7 January 2021

When tuberculosis treatment fails. A social behavioral account of patient adherence

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980026-5

7 January 2021

The brief medication questionnaire: A tool for screening patient adherence and barriers to adherence

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980026-5

7 January 2021

Metered-dose inhaler adherence in a clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980026-5

7 January 2021

The assessment of refill compliance using pharmacy records: methods, validity, and applications

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980026-5

7 January 2021

A general method of compliance assessment using centralized pharmacy records. Description and validation

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980026-5

7 January 2021

Treatment for glaucoma: adherence by the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980026-5

7 January 2021

Assessing compliance to antihypertensive medications using computer-based pharmacy records.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980026-5

7 January 2021

The Effects of Monitoring and Feedback on Compliance

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980026-5

7 January 2021

Introducing medical students to medication noncompliance

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980026-5

7 January 2021

NSAID dosing schedule and compliance

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980026-5

7 January 2021

Measurement of medication compliance in a clinical setting. Comparison of three methods in patients prescribed digoxin

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980026-5

7 January 2021

Compliance of patients with asthma with an experimental aerosolized medication: implications for controlled clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980026-5

7 January 2021

In Search of the Gold Standard for Compliance Measurement

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980026-5

7 January 2021

10.1016/S0149-2918(99)80026-5

Identifiers

DOI

1 reference

28 July 2017

1 reference